ZTS
$71.41+2.47%
as of close, Oct 5, 2026
☾ AH $71.41 +2.47%
ZTS — Zoetis Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeEEEE
60.080.0100.0120.0140.0160.0180.0200.0220.0240.0050.0M$71.41—20162019202120242026
2026-10-05
Price$71.41
MA20$79.23
MA50$110.72
Vol18.7M
Key stats#
Price data
- Price
- $71.41
- YTD price return
- -43.24%
- YTD total return
- -42.35%
- Next earnings
- Nov 5, 2026 · Before open
- Market cap
- 29.5B
- Enterprise value
- 37.1B
- Shares outstanding
- 413.2M
- 52W low
- $68.77
- 52W high
- $148.79
- From 52W high
- -52.01%
- From 52W low
- +3.84%
- 52W range
- 3%
- Beta
- 0.74
Volume
- Rel volume
- 0.80×
- 30D volume
- 4.5M
- 30D $ vol
- 332.9M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- none
- Insider net 3M
- none
- Insider net 1Y
- −$1.7M
Form 4 transactions by trade date, as filed; latest on file 2026-05-13.
Fundamentals
- Sales (ttm)
- 9.5B
- Sales/share
- $23.03
- EPS (ttm)
- $6.08
- FCF (ttm)
- 2.3B
- FCF/share
- $5.60
- Book value/share
- $7.62
- Net margin
- 27.49%
- ROE
- 83.10%
- ROA
- 17.35%
- Debt / equity
- 2.87×
- Current ratio
- 3.08
Growth (CAGR, ttm) · 10Y
- Sales
- +1.49%+5.00%+5.13%+6.96%
- Net income
- +0.97%+5.73%+6.51%+15.15%
- FCF
- +2.07%+21.69%+6.36%+18.14%
- Shares
- -6.76%-3.53%-2.71%-1.79%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +5.44%+8.55%+8.76%+16.87%
- Sales/share
- +8.86%+8.84%+8.05%+8.91%
- FCF/share
- +9.48%+26.15%+9.31%+20.30%
- Book value/share
- -32.18%-8.81%-3.66%+10.77%
- Dividend/share
- +13.79%+15.01%+18.96%+19.68%
- Price
- -50.99%-25.39%-18.33%+3.16%
- Total return
- -50.05%-24.37%-17.40%+4.07%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 11.8×
- Fwd P/E
- 10.7×
- P/S (ttm)
- 3.1×
- P/B (mrq)
- 9.4×
- P/FCF (ttm)
- 12.7×
- EV/EBITDA (fy)
- 9.3×
- EV/Sales (ttm)
- 3.9×
- FCF yield (ttm)
- 7.85%
- Dividend yield (fwd)
- 2.97%
- Dividend yield (ttm)
- 2.93%
- Dividend/share (fwd)
- $2.12
- Buyback yield (realized, 1y)
- 6.76%
- Shareholder yield (realized, 1y)
- 8.05%
- Buyback yield (cash, ttm)
- 12.35%
- Shareholder yield (cash, ttm)
- 15.36%
Vs own 10Y history
- P/E
- 0th
- P/S
- 0th
- P/B
- 0th
- P/FCF
- 0th
Bar = where today’s multiple sits in ZTS’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-05#
1D
+2.47%
5D
-0.03%
1M
-5.80%
3M
-4.53%
YTD
-43.24%
1Y
-51.23%
5Y
-63.65%
Recent filings#
All filings and insider trades →Financial statements
Open full ZTS financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | -0.54% | +0.02% |
| JNJ | Johnson & Johnson | -8.10% | -1.21% |
| ABBV | AbbVie Inc. | +3.63% | +1.12% |
| MRK | Merck & Co. Inc. | -7.18% | -3.30% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | -4.67% | +1.80% |
| TMO | Thermo Fisher Scientific Inc. | +10.26% | +3.35% |
| AMGN | Amgen Inc. | -7.83% | -0.01% |
| GILD | Gilead Sciences Inc. | -4.22% | -0.08% |
